Richard Pomerantz

Chief Scientific Officer at Recombination Therapeutics - , ,

Richard Pomerantz's Colleagues at Recombination Therapeutics
John Oates

Co-founder and CEO

Contact John Oates

Richard Pomerantz's Contact Details
HQ
Location
United States
Company
Recombination Therapeutics
Richard Pomerantz's Company Details
Recombination Therapeutics logo, Recombination Therapeutics contact details

Recombination Therapeutics

, , • 1 Employees
Biotechnology

Recombination Therapeutics is a discovery stage DNA Damage Response (DDR) biotechnology company focused on developing best-in-class personalized cancer therapeutics. Recombination Therapeutics was established in 2018 with the goal of developing next-generation precision medicines for cancers with genetic defects in the DNA repair pathway called homologous recombination. Recombination's lead program is targeting DNA polymerase Theta (Polq) which is essential for the proliferation of recombination deficient cancer cells, but is dispensable for normal cells.

Details about Recombination Therapeutics
Frequently Asked Questions about Richard Pomerantz
Richard Pomerantz currently works for Recombination Therapeutics.
Richard Pomerantz's role at Recombination Therapeutics is Chief Scientific Officer.
Richard Pomerantz's email address is ***@recombinationtx.com. To view Richard Pomerantz's full email address, please signup to ConnectPlex.
Richard Pomerantz works in the Biotechnology industry.
Richard Pomerantz's colleagues at Recombination Therapeutics are John Oates and others.
Richard Pomerantz's phone number is
See more information about Richard Pomerantz